- Custom synthesis of Carbon-14 labelled compounds to support pre-clinical ADME studies
- GMP synthesis of Carbon-14 labelled compounds for human AME studies
- Expertise and facilities for handling labelled gases and volatiles including Carbon Dioxide, Carbon Monoxide and Methyl Iodide.
Projects can be supported either by separate complete syntheses of non-clinical and clinical batches, or by synthesis of a pre-clinical intermediate, which can be used to prepare non-clinical and clinical batches. This second approach can avoid the need for a re-synthesis, saving both time and cost when providing labelled material for the hAME study.
Bio2Business 2018Bio2Business Basel 2018 will be attended by Nathalie Huther, Business Development Manager Europe.
Bio2Business 2018Dates: 19th - 20th JuneLocation: Basel, Switzerland
ChemSpec EuropeThe ChemSpec Europe Conference will be attended by Gareth Jenkins, Chief Scientific Officer at Arcinova. Gareth has been invited to chair 'Sessions 3 and 5' for the Royal Society of Chemistry's Special Symposium, during the two-day event.
ChemSpec EuropeDates: 20th - 21st June 2018Location: Cologne, Germany
Scale-up of Chemical Processes ConferenceThe Scale-up of Chemical Processes Conference will be attended by Nathalie Huther, Business Development Manager Europe.
Scale-up of Chemical Processes ConferenceDates: 25th - 27th JuneLocation: Prague